Hedge Fund - Rhenman & Partners Asset Management
Gilead Sciences Inc. (GILD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $26,163,675 | 3.01% | 233,500 | $103.18 |
| 2 | 2024 - Q4 (2024-12-31) | $23,600,535 | 2.42% | 255,500 | $90.04 |
| 3 | 2024 - Q3 (2024-09-30) | $30,727,360 | 2.49% | 366,500 | $76.30 |
| 4 | 2024 - Q2 (2024-06-30) | $16,363,485 | 1.57% | 238,500 | $66.73 |
| 5 | 2024 - Q1 (2024-03-31) | $9,302,750 | 0.88% | 127,000 | $76.90 |
| 6 | 2023 - Q4 (2023-12-31) | $20,981,590 | 2.09% | 259,000 | $77.82 |
| 7 | 2023 - Q3 (2023-09-30) | $17,535,960 | 1.89% | 234,000 | $76.92 |
| 8 | 2023 - Q2 (2023-06-30) | $18,034,380 | 1.9% | 234,000 | $79.75 |
| 9 | 2023 - Q1 (2023-03-31) | $21,095,550 | 2.31% | 259,000 | $82.83 |
| 10 | 2022 - Q4 (2022-12-31) | $23,179,500 | 2.41% | 270,000 | $79.19 |
| 11 | 2022 - Q3 (2022-09-30) | $21,184,000 | 2.21% | 270,000 | $63.06 |
| 12 | 2022 - Q2 (2022-06-30) | $12,362,000 | 1.4% | 200,000 | $61.91 |
| 13 | 2022 - Q1 (2022-03-31) | $10,107,000 | 0.99% | 170,000 | $63.92 |
| 14 | 2021 - Q4 (2021-12-31) | $20,174,000 | 1.34% | 275,000 | $68.88 |
| 15 | 2021 - Q3 (2021-09-30) | $20,955,000 | 1.47% | 300,000 | $70.25 |
| 16 | 2021 - Q2 (2021-06-30) | $20,658,000 | 1.4% | 300,000 | $66.77 |
| 17 | 2021 - Q1 (2021-03-31) | $22,621,000 | 1.57% | 350,000 | $64.48 |
| 18 | 2020 - Q4 (2020-12-31) | $22,430,000 | 1.82% | 385,000 | $60.34 |
| 19 | 2020 - Q3 (2020-09-30) | $18,325,000 | 1.62% | 290,000 | $69.35 |
| 20 | 2020 - Q2 (2020-06-30) | $17,696,000 | 1.91% | 230,000 | $76.64 |
| 21 | 2018 - Q4 (2018-12-31) | $11,772,000 | 1.34% | 188,200 | $69.90 |
| 22 | 2018 - Q3 (2018-09-30) | $14,643,000 | 1.46% | 189,647 | $75.52 |
| 23 | 2018 - Q2 (2018-06-30) | $18,562,000 | 1.89% | 262,027 | $70.62 |
| 24 | 2018 - Q1 (2018-03-31) | $17,869,000 | 2.2% | 237,027 | $79.49 |
| 25 | 2017 - Q4 (2017-12-31) | $20,471,000 | 2.76% | 285,751 | $75.94 |
| 26 | 2017 - Q3 (2017-09-30) | $12,603,000 | 1.6% | 155,551 | $76.47 |
| 27 | 2017 - Q2 (2017-06-30) | $18,185,000 | 2.61% | 256,916 | $66.54 |
| 28 | 2017 - Q1 (2017-03-31) | $14,054,000 | 2.22% | 206,916 | $70.32 |
| 29 | 2016 - Q4 (2016-12-31) | $18,611,000 | 3.56% | 259,894 | $74.33 |
| 30 | 2016 - Q3 (2016-09-30) | $16,401,892,000 | 2.6% | 207,304 | $81.23 |
| 31 | 2016 - Q2 (2016-06-30) | $20,021,000 | 3.55% | 240,000 | $88.75 |
| 32 | 2016 - Q1 (2016-03-31) | $16,535,000 | 3.28% | 180,000 | $90.18 |
| 33 | 2015 - Q4 (2015-12-31) | $12,548,000 | 1.89% | 124,000 | $104.05 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
2.0000:1.0000 on 2013-01-28